Damaging‐agent sensitivity of Artemis‐deficient cell lines
Antonio Musio(Institute of Biomedical Technologies), Anna Villa(Institute of Genetic and Biomedical Research), Veronica Marrella(Humanitas University), Laura Fariselli(University of Turin), Gaetana Lanzi(University of Brescia), Paolo Vezzoni(Humanitas University), Francesca Rucci(Institute of Biomedical Technologies), Cristina Sobacchi(Humanitas University), Roberto Colombo(Università Cattolica del Sacro Cuore), Silvia Giliani(University of Brescia), Domenico Delia(Fondazione IRCCS Istituto Nazionale dei Tumori), Luigi D. Notarangelo(National Institutes of Health)
Cited by 38
Related Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
|Nature|1998|942
Immune dysregulation in human subjects with heterozygous germline mutations in <i>CTLA4</i>
|Science|2014|844
A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results
|Journal of Clinical Oncology|2012|645